Jounce Therapeutics Inc

NASDAQ:JNCE   1:50:37 PM EDT
7.56
+0.10 (+1.34%)
Other Pre-Announcement

Jounce Therapeutics Reports First Quarter 2021 Financial Results

Published: 05/04/2021 10:57 GMT
Jounce Therapeutics Inc (JNCE) - Jounce Therapeutics Reports First Quarter 2021 Financial Results.
Q1 Loss per Share $0.58.
Ended Quarter With $271.3 Million in Cash, Cash Equivalents and Investments.
Jounce Therapeutics - Expects Existing Cash, Equivalents to Enable Funding of Operating Expenses & Capex Requirements Through Q2 2023.